Content Provider for Newsweek

Interviews

Industry

Priya Abani
Priya Abani
President & CEO
AliveCor
2024-05-11

AliveCor has entered collaborations with CROs and biopharma companies including Novartis and Bristol Myers Squibb to support decentralized clinical trials and patient safety monitoring.

READ MORE
Robert Spignesi
Robert Spignesi
President & CEO
Rapid Micro Biosystems
2024-05-11

We have introduced and plan to continue development of new technologies that leverage our expertise in automated microbial testing, coupled with advances in AI and software to enhance microbial detection and differentiation capabilities.

READ MORE
Adam Schechter
Adam Schechter
Chairman & CEO
Labcorp
2024-05-11

Labcorp's diagnostic segment is dynamic, with over 6,500 tests that span across all therapeutic areas. Our focus is on areas with significant technological advancements such as oncology, neurology, women's health, and autoimmune diseases.

READ MORE
Jim Hollingshead
Jim Hollingshead
President & CEO
Insulet
2024-05-11

Unlike previous generations and competing tubed pumps, Omnipod 5's automated dosing algorithm significantly reduces the need for manual insulin adjustments, enhancing both convenience and clinical outcomes.

READ MORE
Philip Ma
Philip Ma
CEO & Founder
PrognomiQ
2024-05-11

PrognomiQ is focused on harnessing the power of multi-omics data to transform the early detection, treatment selection and recurrence monitoring of cancer and other complex diseases. 

READ MORE
Brian Kim
Brian Kim
CEO
Mission Bio
2024-05-11

The company distinguished itself by focusing on DNA and protein analysis at the single-cell level, a capability that was unique at the time and still is.

READ MORE
Helen Sabzevari
Helen Sabzevari
CEO
Precigen
2024-05-11

We aim to introduce technologies that significantly reduce the cost and time of drug development, thereby naturally lowering drug prices.

READ MORE
Geoffrey McDonough
Geoffrey McDonough
President & CEO
Generation Bio
2024-05-11

Our primary goal has always been to make medicines. The strategic shift we made last year to extend our cash runway was aimed at starting product development, especially focusing on combining our specific delivery technology with genetic cargo.

READ MORE
Amir Aghdaei
Amir Aghdaei
CEO
Envista Holdings Corporation
2024-05-11

Envista aims to deepen its engagement with emerging markets, recognizing the vast potential in regions with low dentists per capita and burgeoning middle classes seeking dental care.

READ MORE
Dr. Omid Farokhzad
Dr. Omid Farokhzad
Chair, CEO & Founder
Seer Inc.
2024-05-11

Seer was founded to address the key challenges faced in the field of proteomics, with the aim to elevate our understanding and technological capabilities up to par with those of genomics.

READ MORE